POPULARITY
Categories
Well-being science reveals that, despite signs of economic growth during the post-COVID recovery, a widespread "vibecession" phenomenon of U.S. consumer pessimism persists. This challenges the traditional economic assumption that increased discretionary income automatically translates into higher national happiness. To explore well-being science, Harvesting Happiness Podcast Host Lisa Cypers Kamen speaks with Dr. Carol Graham, a senior scientist at Gallup, an author, and a senior fellow in the Economic Studies program at Brookings. Carol discusses the lack of civic and economic education in the US and how that affects vulnerable populations. She also presents statistics on the decline of mental health and wellness among US teens and how a loss of hope contributes to consumer pessimism.This episode is proudly sponsored by:Calm—Offers the #1 app for sleep and meditation. Download Calm and find a place made just for you to rest. Visit Calm.com/HHTR Listeners get 40% off a Calm Premium Subscription. and LEAN—Offers clinically formulated weight management blended with ingredients that support metabolism, appetite control, and healthy fat utilization. Visit http://takelean.com/ and use promo code HHTR to get 20% off your order. and Signos—Offers the world's first FDA-cleared AI-driven app and CGM for weight management and wellness that turns data into lasting habits for better health. Visit Signos.com and use promo code HHTR to get $10 off select plans. Like what you're hearing?WANT MORE SOUND IDEAS FOR DEEPER THINKING? Check out More Mental Fitness by Harvesting Happiness bonus content available exclusively on Substack and Medium.
Well-being science reveals that, despite signs of economic growth during the post-COVID recovery, a widespread "vibecession" phenomenon of U.S. consumer pessimism persists. This challenges the traditional economic assumption that increased discretionary income automatically translates into higher national happiness. To explore well-being science, Harvesting Happiness Podcast Host Lisa Cypers Kamen speaks with Dr. Carol Graham, a senior scientist at Gallup, an author, and a senior fellow in the Economic Studies program at Brookings. Carol discusses the lack of civic and economic education in the US and how that affects vulnerable populations. She also presents statistics on the decline of mental health and wellness among US teens and how a loss of hope contributes to consumer pessimism.This episode is proudly sponsored by:Calm—Offers the #1 app for sleep and meditation. Download Calm and find a place made just for you to rest. Visit Calm.com/HHTR Listeners get 40% off a Calm Premium Subscription. and LEAN—Offers clinically formulated weight management blended with ingredients that support metabolism, appetite control, and healthy fat utilization. Visit http://takelean.com/ and use promo code HHTR to get 20% off your order. and Signos—Offers the world's first FDA-cleared AI-driven app and CGM for weight management and wellness that turns data into lasting habits for better health. Visit Signos.com and use promo code HHTR to get $10 off select plans. Like what you're hearing?WANT MORE SOUND IDEAS FOR DEEPER THINKING? Check out More Mental Fitness by Harvesting Happiness bonus content available exclusively on Substack and Medium.
On this accredited episode of NP Pulse: The Voice of the Nurse Practitioner, hear from experts Kathryn Evans-Kreider and Debbie Hinnen, who will be discussing the latest evidence and practical strategies for using continuous glucose monitoring (CGM) to improve outcomes, prevent complications and empower patients. NPs will learn how to apply current guidelines and expand CGM access across diverse patient populations. A participation code will be provided at the end of the podcast — make sure to write this code down. Once you have listened to the podcast and have the participation code, return to this activity in the AANP CE Center. Click on the "Next Steps" button of the activity and: Enter the participation code that was provided. Complete the posttest. Complete the activity evaluation. This will award your continuing education (CE) credit and certificate of completion. CE will be available through Oct. 31, 2026. Podcast Resource: ClinicalBrief_TacklingTherapeuticInertia.pdf This activity is supported by an independent medical educational grant from Abbott Diabetes.
A young listener turns the tables, interviewing Juicebox Podcast host Scott Benner about "fame", family, and 20 million downloads — a heartfelt, funny look at what he's learned along the way. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.
On this episode of Danatech Talks–a special series from The Huddle–Katrina Flaskerud, MS, RDN, LD, CDCES outlines some of the fundamentals of diabetes technology. Katrina provides a foundational overview of all of the devices out there today and how they differ from each other, how to have conversations with clients about what diabetes technology options may be best for them, and how diabetes care and education specialists and other health care professionals who are less familiar with diabetes technology can get started and learn more.This episode was supported by educational grant funding from Abbott.Explore the latest in diabetes technology as well as trainings and resources on danatech: danatech l Diabetes Technology Education for Healthcare Professionals Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Send us a textMost doctors still treat insulin resistance with medication but what if the real cure starts with food?
This week on the StartUp Health NOW podcast, we sit down with Sam Scott, PhD, CEO & Co-founder of Enhance-d, a Switzerland-based company transforming how people with diabetes approach exercise. Sam shares how his experience working with professional athletes living with Type 1 diabetes inspired a digital coaching platform that integrates CGM and wearable data to personalize workouts and improve glucose control. He also talks about the company's new clinical pilots with Dexcom, its growing global community of users, and the next generation of AI-powered coaching tools. Listen in to learn how Enhance-d is helping people with diabetes turn movement into medicine – and why collaboration across sports tech, med tech, and clinical care will shape the future of active diabetes management. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world's biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot PRO Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you're mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Every 8 seconds someone dies from complications of Type 2 Diabetes... Many people accept the medical model that Type two diabetes is a progressive disease that will only worsen but along the way can be managed with medications. Type two IS progressive if you continue to do the things you are doing that got you there in the first place. But what if there were things you could do to not only prevent Type II diabetes, but even reverse it to the point where it not longer exists in those that have it? What if you didn't even have to go to the doctor for this help?That is where "Diabetes Reversal Group" comes in. Dr. Jeffrey Hockings is the founder and CEO of Diabetes Reversal Group. He is also the author of two books on metabolic health and a sought-after speaker on the future of individualized medicine. Dr. Hockings joins us today.This Episode's Blog Page: https://drhaley.com/reversing-diabetesReversing Diabetes Website: https://www.diabetesreversalgroup.net/This episode on YouTube: https://www.youtube.com/watch?v=9JeQq_kOA5gDRG on YouTube: https://www.youtube.com/@diabetesreversalgroup367DRG on Instagram: https://www.instagram.com/diabetesreversalgroup/The Study that shows unvaccinated are healthier:https://www.thegatewaypundit.com/2025/10/bombshell-vax-vs-unvax-study-finally-sees-light/ https://pubmed.ncbi.nlm.nih.gov/33266457/TIMESTAMPS:00:00 Intro Snip01:40 Introduce Dr. Jeffrey Hockings and Diabetes Reversal Group02:23 What is the difference between type 1 and type 2 diabetes?03:16 What is Mainstream Medicine?05:50 What do chiropractors think the proper use of medicine is?07:00 Why did Dr. Jeffrey Hockings get into chiropractic?09:38 What "Power Words" were spoken into Dr. Haley's life by Dr. Bob Schiffman?11:30 What "Power Words" were spoken into Dr. Jeffrey Hockings life?12:54 Are there cases of Type 2 Diabetes that are not reversable?14:22 What other conditions is diabetes causing?16:31 What are the signs of Type 2 diabetes?18:40 How does Diabetes Reversal Group work using telemedicine?20:40 How are medications like Ozempic impacting diabetes treatment?22:20 What is the patient experience like at Diabetes Reversal Group?24:00 How do they monitor their blood sugar levels?25:09 What is better, the finger stick or the CGM?29:23 Dr. Haley invites anyone wearing a CGM to participate in a case study with aloe vera30:25 What is a favorite success story?32:08 What are the blood sugar and A1C measurements to be concerned about?34:24 What are the acceptable blood sugar levels?39:40 What is Dr. Jeffrey Hockings proof that people are brainwashed?42:10 Dr. Hockings discusses a study where vaccinated and unvaccinated children were compared (link in resources).43:29 Dr. Haley explains his "pro-vaccine" approach47:03 Dr. Haley explains his brain washing research48:50 How is exercise incorporated into the program?49:40 How can exercise be bad for a diabetic?54:00 Where is the best first stop to find out more? reverseyourdiabetes.com
Misinformation is aggressively injected into the information ecosystem, and it is readily consumed and adopted by those who are too busy to fully pay attention, leveraging cognitive bias in a distracted society. This media manipulation is often fueled by financial incentives, rewarding so-called experts who deliver false narratives in entertaining and engaging ways. This weighs the heaviest on society when politicians can't agree on policy because they can't agree on facts. To search for the tools of truth, Harvesting Happiness Podcast Host Lisa Cypers Kamen speaks with Dr. Adam Berinsky, author and the Mitsui Professor of Political Science at MIT. Adam dissects the psychology of misinformation, by examining those who create it with malicious intent, the villains who disseminate it for profit, and the audience most likely to adopt it without question. This episode is proudly sponsored by:Signos—Offers the world's first FDA-cleared AI-driven app and CGM for weight management and wellness that turns data into lasting habits for better health. Visit Signos.com and use promo code HHTR to get $10 off select plans. Like what you're hearing?WANT MORE SOUND IDEAS FOR DEEPER THINKING? Check out More Mental Fitness by Harvesting Happiness bonus content available exclusively on Substack and Medium.
Sane Mazibuko's introduction to type 1 diabetes was waking up in hospital after collapsing as a 6-year-old. But as she tells us in this heartfelt episode, being told what to do to manage a health condition is not the same as being told why or how.Growing up in Durban, South Africa, Sane had moved across the country as an adult before she spoke to her first endocrinologist, and after years of confusing and isolating experiences, she eventually found the support team that allowed her to be honest about her condition.29 years into life with type 1 diabetes, Sane now uses the information and experience she's gathered to help others in South Africa and beyond to better understand the life it's possible to live with the condition, from eating the same foods as everyone else to workplace support, to coming back from burnout. As she says on her social media, Sane's decision to ‘choose softness daily', is helping her move through the challenges that type 1 diabetes endlessly presents. Sane also talks poignantly about educating her young daughter about her mum's diabetes, including being able to understand Sane's CGM readings
Misinformation is aggressively injected into the information ecosystem, and it is readily consumed and adopted by those who are too busy to fully pay attention, leveraging cognitive bias in a distracted society. This media manipulation is often fueled by financial incentives, rewarding so-called experts who deliver false narratives in entertaining and engaging ways. This weighs the heaviest on society when politicians can't agree on policy because they can't agree on facts. To search for the tools of truth, Harvesting Happiness Podcast Host Lisa Cypers Kamen speaks with Dr. Adam Berinsky, author and the Mitsui Professor of Political Science at MIT. Adam dissects the psychology of misinformation, by examining those who create it with malicious intent, the villains who disseminate it for profit, and the audience most likely to adopt it without question. This episode is proudly sponsored by:Signos—Offers the world's first FDA-cleared AI-driven app and CGM for weight management and wellness that turns data into lasting habits for better health. Visit Signos.com and use promo code HHTR to get $10 off select plans. Like what you're hearing?WANT MORE SOUND IDEAS FOR DEEPER THINKING? Check out More Mental Fitness by Harvesting Happiness bonus content available exclusively on Substack and Medium.
In this episode of the PCOS Repair Podcast, you'll explore how luteinizing hormone (LH) plays a pivotal role in ovulation, and how its interaction with insulin can create hormonal chaos in PCOS. LH is the hormone responsible for triggering ovulation, but when it becomes imbalanced, cycles can become irregular or even anovulatory. This discussion sheds light on why LH may be elevated and how this elevation disrupts ovulation, especially when paired with high testosterone levels.How Cycle Chaos Unfolds: Elevated LH and OvulationInsulin resistance, common in PCOS, contributes to elevated testosterone and disrupts LH levels. Even without insulin resistance, women with PCOS may experience high insulin levels due to dietary habits. This elevation prompts the ovaries to produce more testosterone, which in turn increases LH. The result? Disrupted ovulation, missed LH surges, and cycles that are difficult to interpret.When LH levels are chronically elevated, the body misses the distinct surge that's necessary for ovulation to occur. You'll discover how this prevents egg release, contributes to cystic ovaries, and leads to inconsistent or missed periods. Practical Tools to Lower Insulin and Restore OvulationYou'll learn practical strategies for lowering insulin and restoring hormone balance. This includes optimizing nutrition and strategic eating patterns to support better glucose regulation and lower daily insulin loads.For deeper insight into how your body handles food and stress, a CGM can be a powerful tool. In this episode, you'll learn how to use a CGM to observe patterns, make small dietary changes, and experiment with meal timing and movement to lower insulin responses and improve hormone balance.Exercise is another key lifestyle tool for improving insulin sensitivity. You'll hear how Zone 2 exercise and strength training help your body use insulin more efficiently. These simple habits can dramatically reduce post-meal glucose spikes and improve overall hormonal function.Stress is a major hormone disruptor. You'll discover how elevated cortisol increases insulin, promotes fat storage, and throws off hormonal rhythms, including LH and ovulation. This episode covers how daily stress management practices are essential to support hormonal healing.Supporting Ovulation with SupplementsOnce foundational root causes are addressed, well selected supplements can further support insulin sensitivity and ovulation. This episode explains when and how to incorporate these supplements and provides resources for trusted product recommendations.If you've struggled to interpret LH tests, manage irregular ovulation, or understand the hidden factors behind PCOS symptoms, this episode breaks it down in a clear, practical way. You'll leave with an understanding of how insulin impacts LH and what daily strategies, like movement, food timing, and supplements, can help regulate this delicate hormonal balance.You can take the quiz to discover your root cause hereGet the PCOS Supplement Guide for trusted product recommendations and discounts. Let's continue the conversation on Instagram! What did you find helpful in this episode and what follow-up questions do you have?The full list of Resources & References Mentioned can be found on the Episode webpage at:https://nourishedtohealthy.com/ep-169
Scott talks with Marley, mom to one-year-old Bane, diagnosed after DKA and a life flight. From ICU to CGM and Mobi, she shares hard-won reality, faith, and growing TikTok advocacy. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof. ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
Hey, I'm Ben Tzeel. In this quick episode, I explain why blood sugars often creep up in fall and it's not just pumpkin treats! We talk about the under the radar role of temperature and season changes, how less daylight and fewer steps can sneakily raise your numbers, and what to check in your data. I share a personal story about steps saving my day and give practical tips: look at your CGM or logs, message your care team about medication adjustments, and plan for holiday foods so you can enjoy them without getting derailed. Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition, and exercise journey! https://www.yourdiabetesinsider.com/free-stuff Watch my food breakdowns here → https://www.youtube.com/@yourdiabetesinsider LET'S TALK! Instagram: @manoftzeel Tiktok: @manoftzeel
Send us a textWe are celebrating five years of podcasting in 2025 by revisiting our archives and rebroadcasting select episodes since June 20, 2020. This is Stephanie Wright. Thank you for joining us for Episode 18, “One Thing” from the Queen Esther series. Let's get started.One thing, one thing. Today, we are asking a very important question. What is that one thing that is holding you back from your blessings? Haman, who had blessings beyond what he deserved could not see the blessings because he was so consumed with hatred for Mordecai. Today, we look at the one thing that led to Haman's demise. Let's go to our presentation, Queen Esther, "One Thing." If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see the most recent video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist." CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/
This week, we're diving into 2 wins, 2 breakdowns, and one massive comeback in our Type 1 Diabetes lives. If you're here for perfect graphs and flawless time-in-range, you're on the wrong podcast. But if you want honesty, swearing, laughter, and actual real-life T1D chaos — welcome home. ❤️In this episode, we talk mental health, time-in-range battles, Libre vs Dexcom drama, night-time spikes, morning glory (yep, still a thing), and why sometimes the biggest win is just not rage bolusing yourself into oblivion. We also bring back Win of the Week and admit which one of us is addicted to crisps. Again.In this episode:
Scott talks with Marley, mom to one-year-old Bane, diagnosed after DKA and a life flight. From ICU to CGM and Mobi, she shares hard-won reality, faith, and growing TikTok advocacy. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
Join Dr. Cecilia Lansang, Associate Editor of Endocrine Practice, Professor of Medicine, and Director of Endocrinology at Cleveland Clinic, as she speaks with Dr. Kristen Flint, Interim Director of Quality and Safety for Endocrinology at Massachusetts General Hospital, Attending Endocrinologist at MGH, and Instructor at Harvard Medical School, about her team's quality improvement project, “Expanding Access to Continuous Glucose Monitoring in Medicare Patients Receiving Specialty Diabetes Care.” This episode covers:Strategies for implementing quality improvement interventions in a large academic diabetes specialty clinicKey interventions that increased CGM utilization, including targeted provider education, workflow optimization, and patient outreachLessons for advancing equitable implementation and sustaining quality improvement over time Tune in for practical insights on bridging policy changes and clinical practice to improve CGM access for Medicare patients. Read the full article in the August 2025 issue of Endocrine Practice here.
Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
Scott and Jenny name and define the blood sugar “shapes” seen on CGM graphs—bell curves, spikes, plateaus, roller coasters—to create a shared language for understanding glucose patterns. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof. ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
Send us a textIn this episode, Anne Lemus, a Fit Body Fusion coach, master's athlete, and menopause advocate, dives deep into the science and strategy behind hormone replacement therapy (HRT) and women's health. She explains the crucial difference between being “medically in range” and being personally optimal, helping listeners understand how to interpret and track their thyroid, cortisol, and hormone panels for genuine well-being. The episode highlights how to properly prepare for lab testing—covering hydration, fasting, and timing—and how lifestyle factors such as sleep, stress management, and nutrition directly influence hormone balance. With practical insights on functional health, inflammation, and continuous glucose monitoring (CGM), Anne empowers women to take charge of their health and discover what true hormonal balance feels like.Anne Lemus is a dedicated IFBB Bikini Pro and experienced Fitness & Nutrition Coach, empowering individuals to transform their health and achieve their physique goals through balanced strategies and sustainable habits. With a strong foundation in competitive bodybuilding, Anne uses her expertise to guide clients through tailored fitness programs and personalized nutrition plans that promote strength, confidence, and long-term success. Her journey as a professional athlete fuels her passion for helping others unlock their full potential, whether they're stepping on stage or striving for a healthier lifestyle. Anne's coaching philosophy focuses on creating balance, fostering self-discipline, and embracing the mindset needed for lasting results.
An ICU nurse mom recounts her child's type 1 diabetes DKA diagnosis, winning school CGM monitoring, juggling celiac, and data-driven management with pump/CGM—practical advocacy and tactics parents can replicate. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it.
If you've ever been told your blood sugar is “normal” but you still feel tired, anxious, or can't sleep, this episode is for you.Most people think blood sugar only matters if you have diabetes. But the truth is, your blood sugar impacts every single system in your body... from your energy and sleep to your hormones, cravings, and mood.In this episode, Dani breaks down what blood sugar actually does in the body, the subtle signs it's off (even when your labs look fine), and how modern life, from artificial light to chronic stress, quietly disrupts metabolic health. You'll learn why these issues go far beyond food and how your circadian rhythms, nervous system, digestion, minerals, and mitochondria all play a role in keeping you balanced.You'll walk away understanding why steady blood sugar is foundational for optimal energy, hormones, mood, and long-term health.
Send us a textA 35% drop in liver fat in under a week sounds impossible—until you see how a simple macro shift can redirect your metabolism. We dive into a Danish crossover study where calories stayed equal, protein held steady, and the only real change was carbohydrates versus fat. The result: rapid reductions in hepatic fat, lower triglycerides, improved insulin sensitivity, and clear signs of metabolic flexibility, all in four to five days. We unpack what that means for everyday eating, how to use CGM feedback to reduce glucose spikes, and why outcomes like organ fat and fat oxidation should trump a single lipid reading taken out of context.From there, we widen the lens. Fatty liver—now recognized as a hallmark of metabolic dysfunction—is staggeringly common, yet highly responsive to nutrition quality and distribution. We break down why modest carb moderation paired with quality fats and robust protein can stabilize energy, support endogenous GLP-1 signaling, and protect lean mass. We also confront a common confusion: “high fat” isn't a license for ultra-processed oils or low-fiber meals. When fats come from olive oil, avocado, nuts, eggs, and fish—and plants supply fiber and polyphenols—the microbiome, mitochondria, and glycemic control can all improve together.We close with practical implications for anyone using GLP-1 medications. Pharmacology can provide short-term traction, but it doesn't guarantee nourishment. A protein-forward, lower-glycemic template plus resistance training helps preserve muscle, sustain satiety, and potentially reduce medication reliance over time. If you're ready to swap shaky biomarkers for meaningful outcomes—and to see changes fast—this conversation offers a clear, evidence-backed roadmap. If it resonates, follow the show, share with a friend, and leave a quick review to help more listeners find The Health Edge.www.thehealthedgepodcast.com
In this episode of The Lisa Fischer Said Podcast, Lisa sits down with Kara Collier, registered dietitian and co-founder of Nutrisense, to unpack the truth about metabolic health, insulin resistance, and how continuous glucose monitors (CGMs) are transforming the way we understand our bodies. Kara shares why she left traditional healthcare, the shocking flaws in hospital nutrition, and how real-time data from CGMs empowers behavior change. Whether you're keto, carnivore, plant-based, or just curious, this episode reveals why everyone should wear a CGM at least once. Learn how glucose, insulin, fasting, aging, and hormones all play into the metabolic puzzle—and how Nutrisense is helping thousands take control of their health. WEBSITE: https://www.karacollier.com/courses/GlucoseAcademy Nutrisense Page with 33% Discount: https://www.nutrisense.io/marketing/kara-collier INSTAGRAM: https://www.instagram.com/karacollierrd/ INSTAGRAM: https://www.instagram.com/nutrisenseio/ FACEBOOK: https://www.facebook.com/nutrisenseio EPISODE SPONSOR: https://www.davidsburgers.com/ EPISODE SPONSOR: https://marlsgate.com LISA'S LINKS: Lisa Fischer Said Academy: https://lisafischersaid.com/academy/ Website: lisafischersaid.com For more information on group intermittent fasting coaching with Lisa, email fasting@lisafischersaid.com For more information on one-on-one or group health coaching with Lisa, email healthcoaching@lisafischersaid.com Podcast produced by clantoncreative.com
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX French drugmaker Sanofi says it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status. The program, originally meant for uninsured diabetes patients, would now include those with commercial insurance or Medicare, the drugmaker said. Patients will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for the fixed monthly price of $35, starting January 1. Lilly and Novo also have similar programs through which they offer insulin products for $35 a month for U.S. patients regardless of whether the patients have insurance. There is no law at work here – the only legislation that has changed the price of insulin came with the Inflation Reduction Act in 2022 with the Medicare cap. Helping lower the cost here, biosimilars hitting the market and the huge profitability for GLP-1 drugs for Novo and Lilly https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-offer-all-insulin-products-35-per-month-us-2025-09-26/ XX A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib (bare-uh-SIT-nib) safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes.. and their diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels. Baricitinib works by quelling signals in the body that spur on the immune system, and is already approved for treating autoimmune conditions such as rheumatoid arthritis, ulcerative colitis and alopecia, researchers said. “Among the promising agents shown to preserve beta cell function in type 1 diabetes, baricitinib stands out because it can be taken orally, is well tolerated, including by young children, and is clearly efficacious,” Waibel said. “We are hopeful that larger phase III trials with baricitinib are going to commence soon, in people with recently diagnosed type 1 diabetes as well as in earlier stages to delay insulin dependence,” she added. “If these trials are successful, the drug could be approved for type 1 diabetes treatment within five years.” Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal. https://www.usnews.com/news/health-news/articles/2025-09-23/pill-effective-in-slowing-type-1-diabetes-progression XX An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. The Drug, called ATG, is currently used together with other medicines to prevent and treat the body from rejecting a kidney transplant. It can also be used to treat rejection following transplantation of other organs, such as hearts, gastrointestinal organs, or lungs. The researchers studied 117 people aged five to 25, who'd been diagnosed with type 1 diabetes within the past three to nine weeks. The participants were from 14 centers across eight European countries and were randomized to be given different doses of ATG (0.1, 0.5, 1.5, or 2.5 mg/kg) or a placebo. ATG was given as a two-day intravenous (IV) infusion. The main goal was to see how well the pancreas could still make insulin after 12 months, measured by C-peptide levels during a special meal test. C-peptide is released into the blood along with insulin by the pancreas. The findings are promising, showing that ATG, even at a relatively low dose, can slow the loss of insulin-producing cells in young people newly diagnosed with type 1 diabetes. The lower dose also caused fewer side effects, making it a more practical option. https://newatlas.com/disease/antithymocyte-globulin-newly-diagnosed-type-1-diabetes/ XX The FDA has delayed its feedback on Lexicon Pharmaceuticals' application to bring Zynquista (sotagliflozin) to people with type 1 diabetes. The agency had planned to respond this month but will now wait until the fourth quarter after reviewing new data from ongoing studies. Zynquista, an oral drug meant to be used with insulin, has already been approved for heart failure (marketed as Inpefa). But in type 1 diabetes, it faces safety concerns: last year an FDA advisory committee voted 11–3 that its benefits don't outweigh the increased risk of diabetic ketoacidosis (DKA). The FDA later issued a complete response letter rejecting the drug. Lexicon is still pushing forward, hoping its additional submissions will strengthen Zynquista's case for type 1 diabetes approval. https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay XX A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide. A new study found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition. G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test—which diagnoses and monitors diabetes—appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment. The study found men with G6PD deficiency are at a 37% higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes. "This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late." https://medicalxpress.com/news/2025-09-hidden-genetic-delay-diabetes-diagnosis.html XX Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli® would become the first once-weekly basal insulin available in the United States, providing an alternative to daily basal insulin injections for adults living with type 2 diabetes. The resubmission is based on results from the ONWARDS type 2 diabetes phase 3a program for once-weekly Awiqli® which is comprised of five randomized, active-controlled, treat-to-target clinical trials in approximately 4,000 adults with type 2 diabetes. The clinical program evaluated Awiqli® vs. daily basal insulin and the primary endpoint in these trials was change in A1C from baseline.1-5 Awiqli® is approved in the EU, along with 12 additional countries. In addition, regulatory filings have been completed in several other countries, with further regulatory decisions expected in 2025. XX Interesting news from Sequel Med Tech – they've signed an agreement with Arecor to pair the twiist pump with AT278 an ultra-concentrated (500U/mL), ultra-rapid insulin in development. They also have a deal with Medtronic to develop insulin for new pumps. This insulin isn't yet approved, it's 5 times stronger than standard fast acting it's hoped that a clinical study will begin next year. Arecor says its insulin could potentially be the only option capable of enabling and catalyzing the next generation of longer-wear and miniaturized automated insulin delivery systems. https://www.drugdeliverybusiness.com/sequel-arecor-develop-rapid-insulin-twiist/ XX Tandem Diabetes Care announes its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United States (U.S.). – The t:slim X2 insulin pump with Control-IQ+ technology is now cleared for use with Lyumjev for people with type 1 diabetes ages 2 and above and all adults with type 2 diabetes. The companies are continuing to work toward securing Lyumjev compatibility for the Tandem Mobi pump. https://hitconsultant.net/2025/09/29/tandem-diabetes-cares-tslim-x2-pump-cleared-for-use-with-lillys-ultra-rapid-lyumjev-insulin/ XX You can now place your order for the MiniMed™ 780G system with the Instinct sensor, made by Abbott. And if you are already a MiniMed 780G user, you can place an upgrade order today. This is a 15 day wear sensor, with no transmitter or overtape required. It looks the same at other Abbot sensors such as the Libre but is proprietary to Medtronic. Shipments are scheduled to start in November. https://www.drugdeliverybusiness.com/medtronic-launches-minimed-780g-instinct-abbott/ XX The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates. , The study estimates that T1D will affect 9.5 million people globally in 2025 (up by 13% since 2021), and this number is predicted to rise to 14.7 million in 2040. However, due to lack of diagnosis and challenges in collecting sufficient data, the actual number of individuals living with T1D is likely much higher, researchers say. In fact, they estimate that there are an additional 4.1 million 'missing people' who would have been alive in 2025 if they hadn't died prematurely from poor T1D care, including an estimated 669,000 who were not diagnosed. This is particularly true in India, where an estimated 159,000 people thought to have died from missed diagnoses. The study predicts that 513,000 new cases of T1D will be diagnosed worldwide in 2025, of which 43% (222,000) will be people younger than 20 years old. Finland is projected to have the highest incidence of T1D in children aged 0-14 years in 2025 at around 64 cases per 100,000. The substantial increases in T1D forecasts between 2025 and 2040 underscore the urgent need for action. As co-author Renza Scibilia from Breakthrough T1D explains, "Early diagnosis, access to insulin and diabetes supplies, and proper healthcare can bring enormous benefits, with the potential to save millions of lives in the coming decades by ensuring universal access to insulin and improving the rate of diagnosis in all countries." The authors note some important limitations to their estimates, including that while the analysis uses the best available data, predictions are constrained by the lack of accurate data in most countries-highlighting the urgent need for increased surveillance and research. They also note that data on misdiagnosis and adult populations remain limited, and the analysis assumes constant age-specific incidence and mortality over time. Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Future updates are expected to improve as new data become available and applied. https://www.news-medical.net/news/20250919/New-study-warns-of-millions-of-undiagnosed-and-missing-people-with-type-1-diabetes.aspx XX A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy. Researchers estimate that as much as 40% of all people with diabetes also have diabetic retinopathy — a potentially blinding eye condition caused by blood vessel damage in the eye's retina. There is currently no cure for diabetic retinopathy. The condition is often managed through injections of anti-VEGF medications into the eye, surgery, and blood sugar monitoring and control. For this lab-based study, researchers used samples of human retinal endothelial cells that were treated with different concentrations of semaglutide. The cells were then placed in a solution with both a high glucose level and high level of oxidative stress — where there is an imbalance of antioxidants and free radicals — for 24 hours. Past studies show that oxidative stress plays a role in the formation of diabetic retinopathy. At the study's conclusion, researchers found that the retinal cells treated with semaglutide were twice as likely to survive than cells that were untreated. Additionally, the treated cells were found to have larger stores of energy. Scientists also found that three markers of diabetic retinopathy were decreased in the semaglutide-treated retinal cells. First, the levels of apoptosis — a form of cell death — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The production of the free radical mitochondrial superoxide decreased from about 90% to about 10% in the treated retinal cells. Researchers also found the amount of advanced glycation end-products — harmful compounds that can collect in people with diabetes and are known to cause oxidative stress — also decreased substantially. Lastly, scientists reported that the genes involved in the production of antioxidants were more active in the semaglutide-treated cells when compared to untreated cells. Researchers believe this is a sign that semaglutide may help repair damage to the retinal cells. “Our study did not find that these drugs harmed the retinal cells in any way — instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher at the National and Kapodistrian University in Greece, and lead author of this study, said in a press release. “Excitingly, these drugs may be able to repair damage that has already been done and so improve sight. Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.” https://www.medicalnewstoday.com/articles/ozempic-semaglutide-may-help-protect-against-diabetes-related-blindness-retinopathy XX Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. This one is tricky – it's called a needle free CGM but it also says it uses micro needles. By the way, De Novo isn't exactly the same as what we think of for FDA approval for medical devices. It's not as rigorous but it's a streamlined route for novel, low to moderate risk devices with no existing equivalent. We'll see how this one turns out. https://www.hmenews.com/article/biolinq-s-multi-function-biosensor-receives-fda-de-novo-classification
‣ Book Your COMPLEMENTARY CONSULATION and CALORIE CALCULATION call:- how much & what to eat, exercise & lifestyle recommendations, and specific resources to support you on your journey
The glucose projector is a simple but powerful idea that can only come from someone who lives with type 1 – and sleeps with it! John DeLeo created a digital readout of CGM data that displays the number, and the time, right on the ceiling. John was diagnosed with type 1 in his 40s. We'll talk about his diagnosis, what lead him to this invention, the long road of bringing it to market, and more. Learn more about Glucose Projector here This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at an upcoming Moms' Night Out event! Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.
Health technologist and science communicator Caitlin Shure (NextSense) joins me to unpack brainwave-measuring earbuds that can both read and change your mental state—starting with sleep. We dive into why “Gen-1” wearables overwhelm you with charts but don't help you in the moment, how earbud-EEG works (yes, with just three electrodes), the messy truth on EMF fears, and why women—especially moms—need “do-it-for-me” tools, not just dashboards. This episode is for women—especially busy moms and high-achievers—who want better sleep, calmer days, and science-backed wearables that actually help (not just track). WE TALK ABOUT: 05:00 - Caitlin's origin story: From “not a science person” to neuroscience and science communication 06:20 - Making complex brain science click for everyday life (and why wearables help) 09:55 - Why “one new idea at a time” beats info overload in health education 10:20 - Early neurotech (Muse), then Apple Watch, Oura, CGM—what worked and what didn't 13:20 - Why “wearable must be wearable”: Rings, watches, now earbuds near your brain 14:30 - Starting with sleep: The lowest-hanging lever for memory, mood, and cognition 19:40 - Neurons, synchrony, and how three earbud electrodes capture EEG 24:50 - Women's health use-cases: Pregnancy, postpartum, perimenopause, menopause 29:05 - “Numbers, not judgments”: Why NextSense won't label your sleep ‘good' or ‘bad' 34:30 - What's next: Adaptive Focus and Relaxation sessions (neurofeedback-like audio) 36:30 - Binaural beats: Mixed evidence, likely responders vs non-responders SPONSORS: CaloCurb (get 10% OFF) is my go-to, 100% plant-based alternative to Ozempic—helping you feel full sooner, snack less, and finally trust your body again without needles, drugs, or yo-yo diets. Join me in Costa Rica for Optimize Her, a 5-night luxury women's retreat in Costa Rica with yoga, healing rituals, and biohacking workshops—only 12 spots available. RESOURCES: Trying to conceive? Join my Baby Steps Course to optimize your fertility with biohacking. Free gift: Download my hormone-balancing, fertility-boosting chocolate recipe. Explore my luxury retreats and wellness events for women. Shop my faves: Check out my Amazon storefront for wellness essentials. NextSense website and Instagram Caitlin Shure's website LET'S CONNECT: Instagram, TikTok, Facebook Shop my favorite health products Listen on Spotify, Apple Podcasts, YouTube Music
Fit Mother Project Podcast number 166 introduces us to Dr. Melissa Mahan. A 59-year-old grandmother of six, higher-ed leader, and certified professional coach from San Antonio who refused to let family history dictate her future. After a routine checkup in early 2024 revealed an A1C of 6.6 with high cholesterol and blood pressure, she chose a structured, natural path over medication—and found the Fit Mother Project. What followed was a systems-driven transformation built on consistent action, community support, and faith. Within months, Melissa dropped her A1C to ~6.0, normalized her blood pressure, improved her lipid ratios, and lost ~35 pounds—largely by dialing in “protein first,” lifting consistently, and stacking simple habits like morning sunlight walks. She also learned powerful glucose-management strategies through a CGM, discovering how pairing protein/fiber (and avoiding “spike-on-a-spike” combos like soda before pizza) dramatically changed her numbers. Melissa shares the tweaks that mattered (e.g., swapping coconut milk for almond milk in shakes and adding psyllium husk), along with her mantra of the “relentless return”—not perfection, but always coming back to the next right action. She describes how Fit Mother retreats, small-group coaching, and the in-app sisterhood reinforced mindset shifts, helped her navigate menopause challenges, and kept her on track during celebration-heavy seasons. Now, just shy of 60, Melissa is training for senior-level cycling events and planning a 500-mile Camino de Santiago ride in Spain—proof that health creates possibilities. Her challenge to listeners: dare to dream, set a meaningful goal, and finish this year strong.Key Takeaways:A1C 6.6 → ~6.0; BP/lipids trending normal~35 pounds down; energy and mood up“Protein first” meals; stronger satiety, fewer cravingsCGM insights; smarter food order and pairingSkip soda-before-pizza; avoid “spike on a spike”Fiber + protein before carbs; steadier glucoseAlmond milk swap; lower sugar, cleaner shakesPsyllium add-in; soluble fiber, better fullnessMorning sunlight + 20–30 min walk stackStrength training 2–4x/week; progressive overloadPower-meter cycling; targeted endurance gainsRetreats + small groups; consistent accountabilityMenopause-aware tweaks; sleep and stress prioritized“Relentless return” mindset; progress over perfectionBig goal: 500-mile Camino; senior cycling eventsWant To Change Your Life? Check Out Foundations!Foundations is a simple, sustainable, and specific weight loss program designed especially for busy women over 40. With short metabolic training workouts, an easy-to-follow meal plan, and an accountability team there for you every step of the way, Foundations can help you lose weight, regain energy and vitality, and live life to the fullest. Click here to see everything you get when you join FM30X, subscribe to our YouTube Channel, check out our blog, and follow us on Instagram, TikTok, Facebook,
Send us a textHello and welcome to our series “Stay in His Presence.” We are celebrating five years of podcasting by going into our vault, remastering, and rebroadcasting select episodes since June 2020. Last week, we heard the miracle testimony of Michael Dudley and how the Lord healed him from prostate and colon cancer. This week, we will listen to another miracle testimony from Andrea Dudley, his wife, as presented on August 21, 2021. Andrea is the CEO of Habakkuk Publishing, established in 2006. A Christian company that publishes books which inspire, encourage, and impact the lives of people.My name is Stephanie Wright. Let's go to Andrea's encouraging message of Hope Beyond Brokenness. If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see the most recent video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist." CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/
This episode is brought to you by Erin's brand new digital workbook, "Diabetes, Liberated: An Anti-Diet Digital Workbook to Help You Thrive with Type 2 Diabetes." Check it out here: https://www.erinphillipsnutrition.com/workbook and use this link to get 20% off. In this episode, we talk with Beck (they/them), a trans, nonbinary 28-year-old, about their experience navigating a new diabetes diagnosis. A couple of notes: We recorded this back in DECEMBER, and then life got lifey! Better late than never, because we'd hate for you to miss out on this great interview!Erin was sick when we recorded, so apologies for the cough drop sounds for our sensory sensitive friends!In this episode we talk about: How Beck navigated being diagnosed on the young side, and how to process guilt and shame after a diabetes diagnosis.Finding a supportive care team to help you navigate a diabetes diagnosis.Type 2 diabetes vs latent autoimmune diabetes in adults (LADA, sometimes called type 1.5 diabetes), and navigating a shifting diagnosis.Balancing eating disorder recovery with a new diabetes diagnosis.How Beck adjusted their relationship with their CGM (continuous glucose monitor) to use it as a tool for support rather than a tool for punishment.Ways that Beck found helpful to protect themself from weight stigma.Let us know what you think! LINKS:Apply to be on the podcast! Find out more about Kelly hereFind out more about Erin hereDISCLAIMER: We are dietitians and diabetes educators but we are not YOUR dietitians and diabetes educators. The information provided in this podcast is not intended as individualized medical advice, nor is it a substitute for professional medical expertise or treatment. If you have a medical concern, go to your health care provider or seek other professional medical treatment.
The relationship between diabetes and obesity was explained in simple terms, highlighting how excess weight leads to insulin resistance. As obesity increases, the effect of insulin in the body decreases. To compensate, the pancreatic beta cells have to work harder to maintain normal blood sugar. Over time, this constant strain on beta cells causes beta cell fatigue and eventual failure. Insulin is secreted from beta cells in two phases. The first phase of insulin release covers the postprandial spike of glucose, while the second phase continues its action for 4–6 hours. In type 1 diabetes, both these phases of insulin release are absent, which is why insulin replacement becomes absolutely necessary. While in T2DM, the first phase of insulin is lost, causing postprandial hyperglycemia. Dr. Gupta emphasized that HbA1c alone cannot provide a complete picture of diabetes control. While it reflects the average sugar level, it does not capture dangerous fluctuations. Glycemic variability—frequent ups and downs in sugar—poses a high risk, and therefore continuous glucose monitoring (CGM) is extremely valuable. CGM not only shows the average but also the trends and time-in-range, helping patients and doctors achieve better stability. Dr. Kavita Gupta mainly focused on lifestyle and diet management. She explained the benefits of intermittent fasting and early dinner, pointing out that heavy meals late at night increase both sugar and weight. She suggested the “plate method” of eating: half the plate vegetables, one-fourth pulses or proteins, and one-fourth complex carbohydrates. She emphasized salads, sprouts, yogurt, and the importance of portion control. Addressing common confusion about fruits, she clarified that diabetic people can safely eat seasonal fruits in moderation, as long as juices are avoided and quantity/timing are considered. She also recommended a light “pre-dinner snack” such as fruit between lunch and dinner to prevent hypoglycemia and curb junk food cravings. Her overall message was clear: balanced diet, correct timing, and mindful eating are essential pillars of diabetes care. Expert- Dr Sunil Gupta & Dr Kavita Gupta Anchor- Mrs. Kalyani Gokhale Podcast: 23/05/2025 Recorded at: Akashwani Nagpur Episode: 76
Although aging is an inevitable part of life, there are many factors in our control that can help us live long, vibrant lives. Through healthy lifestyle habits, you can actually slow down the biological aging process. Today, you're going to learn the key strategies that can help you reach this goal. On this episode of The Model Health Show, you're going to learn about seven science-backed ways you can slow down your aging process. We're going to cover supplementation, exercise, mindset, and so much more! You're going to hear the latest studies on antiaging, plus tips from some of the top longevity experts. Plus, for each of these tips, I'm going to share some tangible takeaways you can implement immediately. If you want to slow down your aging process and get healthier as you age, this episode is for you. Enjoy! In this episode you'll discover: How vitamin D supplementation can reduce telomere shortening. (0:42) What telomeres are. (1:30) The percentage of Americans that are vitamin D deficient. (2:07) Which form of vitamin D to take for antiaging benefits. (3:18) How your sleep quality impacts biological aging. (4:30) The link between sleep and telomeres. (5:32) Why having a consistent sleep schedule is critical for your health. (6:05) The role of sunlight exposure in regulating your circadian rhythm. (13:39) How your gut microbiome can dictate your aging process. (22:45) The importance of eating a diverse range of foods. (26:31) How many servings of fermented foods per week to eat for gut health. (31:09) Why meditation can slow down your aging process. (31:30) The power of having adequate muscle on your body. (38:37) How much tea to drink daily for antiaging effects. (46:08) The incredible role your mind plays in impacting your rate of aging. (49:40) Why being playful can help you live longer. (58:02) Items mentioned in this episode include: Levels.link/model - Join today and get 2 free months with a one-year membership! Piquelife.com/model - Get exclusive savings on bundles & subscriptions! These 4 Things Are Destroying Your Sleep Quality - Get better sleep tonight! Eat These Foods to Improve Your Sleep Quality - Learn about the link between nutrition & sleep! Visualization Secrets Athletes Use - Hear the interview with Maya Raichoora Seasonal Food Guide - Find which foods are in season in your area! Be sure you are subscribed to this podcast to automatically receive your episodes: Apple Podcasts Spotify Soundcloud Pandora YouTube This episode of The Model Health Show is brought to you by Levels and Pique. Learn how food affects your health with a continuous glucose monitor (CGM) from Levels. Join today at levels.link/model and get 2 free months with a one-year membership! Go to Piquelife.com/model for exclusive savings on bundles & subscriptions on cutting-edge solutions for your head-to-toe health and beauty transformation.
B is the mom of a T1D son who was diagnosed at a 16 months. He is currently 2 and they are about 9 months in to managing diabetes. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
I am delighted to have Jessie Inchauspé, the Glucose Goddess, joining me on the podcast today! Metabolic health is my passion! It is a huge area of focus in my work, and Jessie is truly a gift in the space! She is a rising star author and biochemist with a clear and accessible way of explaining the science behind glucose metabolism. Jessie joins me today to discuss the impact of glucose metabolism and spikes. We dive into her background and how an accident created her pain-to-purpose story. We discuss the role of continuous glucose monitors and how glucose spikes impact our mitochondria, inflammation, and oxidative stress. We get into glycation and aging, how weight gain is a protective aspect of glucose spikes- or hyperglycemia, and the role of vinegar, movement, and fiber. We also talk about Jessie's new book, her opinions on fasting, and so much more. I loved interviewing Jessie! Her enthusiasm is contagious, and it is easy to understand why she is such a beloved author in the health and wellness space! IN THIS EPISODE YOU WILL LEARN: Jessie shares how an accident led her to where she is today. Wearing a continuous glucose monitor (CGM) changed everything for Jessie How Jessie developed her simple principles to stabilize glucose levels What is the purpose of glucose in the body? Glucose spikes and our mitochondria Vinegar hack for reducing side effects and symptoms of glucose spikes Being metabolically unhealthy impacts the aging process Benefits of having savory breakfasts and eating vegetables first with every meal Jessie's book, The Glucose Goddess Method How gaining weight protects our bodies from the impact of glucose spikes Walking or moving after meals to balance blood sugar levels Why blood sugar so important Connect with Cynthia Thurlow Follow on X Instagram LinkedIn Check out Cynthia's website Connect with Jessie Inchauspé On her website Instagram Link for Jessie's new book: Buy a copy of Jessie's book, The Glucose Goddess Method.
Dr. Hoffman continues his conversation with Jim LaValle, a clinical pharmacist and certified clinical nutritionist, detailing cholesterol's importance and its implications for cardiovascular health.
September is Cholesterol Education Month. In this episode of Intelligent Medicine, Jim LaValle, a clinical pharmacist and certified clinical nutritionist, details cholesterol's importance and its implications for cardiovascular health. He delves into the nuances of cholesterol types, the historical shifts in perceptions of cholesterol, and how dietary and lifestyle factors influence cholesterol levels and cardiovascular risk. Jim provides expert insights into the roles of LDL and HDL cholesterol, the significance of cholesterol particle size, the impact of carbohydrates on cholesterol, and the benefits of aged garlic extract and other supplements. The conversation emphasizes the importance of comprehensive lipid testing, understanding individual risk factors, and integrating both lifestyle modifications and, when necessary, medications into cardiovascular preventive strategies. The episode concludes with a discussion on the role of health policies and the future of integrative health approaches.
Text us a comment or question!Ever wonder why some foods leave you energized and satisfied while others knock you into a mid-afternoon crash - or make fat loss feel impossible? The answer lies in your blood sugar. And today, we're breaking down how you can finally take control of it. In this episode, I sit down with Kara Collier, co-founder and VP of Health at Nutrisense, to uncover how continuous glucose monitoring (CGMs) and smart lifestyle strategies can help you outsmart stubborn fat, reclaim your energy, and build the lean, strong body you deserve in your 50s, 60s, and beyond. Kara is a Registered Dietitian and one of the leading voices in metabolic health. She's helped over 150,000 people use real-time data and practical tools to create sustainable change - and today, she's sharing those insights with you. What you'll learn in this episode:Why blood sugar spikes and crashes sabotage fat loss, energy, and cravingsThe surprising individuality of how foods affect your glucose (bananas might not be the villain after all!)Simple hacks to keep blood sugar balanced - without giving up your favorite foodsHow stress, sleep, and even the time of day can dramatically impact your glucose responseWhy building muscle is one of the most powerful tools for metabolic healthSupplements and “biohacks” that actually move the needle (and which ones are just pebbles, not boulders) Whether you're struggling with stubborn belly fat, daily energy crashes, or just want to feel younger and more vibrant, this conversation will show you how to finally master The Glucose Game.
Blood sugar impacts everything—your energy, your sleep, your hormones, your brain, your heart, your thyroid, EVERYTHING. Yet most of us only hear about it in the context of diabetes. In this episode of the Nutritional Therapy and Wellness Podcast, host, Jamie Belz, and fellow NTP, Ashley Lawrence, open the curtain on the real story behind why blood sugar is often the hidden root behind symptoms like PCOS, anxiety, insomnia, weight struggles, and even long-term risks like cardiovascular disease and Alzheimer's. Ashley—known as the “Blood Sugar Bestie”—shares her personal journey of misdiagnosis, failed quick fixes, and finally discovering that blood sugar balance changes everything. Ashley shares: Her hopeful testimonial story and what she did to “lose her PCOS diagnosis.” Why PCOS is more than “just a hormone disorder”—and how insulin resistance drives much of the imbalance. Why some researchers call Alzheimer's “type 3 diabetes,” and what that really means. How early warning signs like skin tags and darkened patches can show up years before a diagnosis. The reality that blood sugar issues can simmer silently for a decade or more before being labeled diabetes. Practical, joy-filled strategies: pairing carbs with protein, food + mood journaling, hydration hacks, and short-term CGM (Continuous Glucose Monitor) experiments to see what works for your bio-individual body. CLEAN FATS make healthy hormones! (ALL natural fats are healthy - they need to be unadulterated and from clean sources.) This episode isn't about restriction. It's about freedom—learning how simple, everyday choices restore balance, resilience, and joy. Want to go deeper? Continue your journey with these complimentary episodes:: Episode 46: Wellness 101 – A Common Sense Start Episode 28: Blood Sugar 101 — a deeper dive into the basics of glucose, insulin, and cravings. Episode 53: Dr. Lindsey Berkson - Hormones, Libido, and Longevity Connect with Ashley: Instagram: @magicandwellness Website: magicandwellness.com Blood Sugar Bootcamp https://l.bttr.to/sEVmp Don't forget to subscribe, leave a review, chat with us on Spotify, SHARE, and help change the world! NOTE: To date, NTA/Jamie are neither affiliated nor receiving compensation of any kind for this or any other product or service featured on The Nutritional Therapy and Wellness Podcast. We simply love connecting good people with other goodness.
This week on We Are T1D, Mike and Jack tackle the ins and outs of Continuous Glucose Monitors (CGMs) — those little gadgets that keep an eye on your sugars around the clock, often with a bit of drama thrown in for good measure. From the beeping alerts that can wake you at 3 AM to the occasional sensor mishap, they explore how these devices can be both lifesavers and sources of anxiety.Join the duo as they delve into the specifics of CGMs, including their functionality, the different types available in the UK, and why trend arrows are a game changer. They share personal anecdotes, laugh at the chaos that comes with using CGMs, and even take a peek at some hilarious Reddit stories about sensor mishaps.What to Expect:The basics of how CGMs work and why they're essential for Type 1 diabeticsThe difference between the Dexcom and Libre systemsReal-life tales of sensor struggles and triumphsTips for keeping your CGM stuck on, even through showersFuture tech: What could CGMs look like in the coming years?“Without CGMs, diabetes would be 100 times harder.” – MikeConnect with Us:Email: wearet1dpodcast@gmail.comWebsite: www.wearet1d.comInstagram: @t1d_mike & @t1d_jackWhatsApp Community: Join hereExtra Resource:Diabetes UK – Continuous Glucose MonitoringHashtags:#Type1Diabetes #T1DLife #DiabetesPodcast #WeAreT1D #T1DCommunity #CGM #DiabetesTech
Exercise scientist and biohacking pioneer PJ Glassey (founder, X-Gym; author, Cracking Your Calorie Code) joins the Gametime Guru to deliver a playbook for busy athletes: morning hydration that actually absorbs, nutrition on the road for tournaments and travel, and a 21-minute, twice-weekly time-under-tension program that builds precision, coordination, and strength without beating up your joints. We also cover brain-type-based discipline loops, smart use of wearables (Oura, CGM, Apple Watch), and how cold plunge + sauna can boost recovery and mental toughness. Topics: • Hydration: electrolytes, morning rehydration, performance cost of 2–4% dehydration • Travel nutrition: grocery/mini-fridge hacks, protein + veggies first, better fast-food choices • Training: TUT explained, slow-rep precision, nerve training for coordination • Mental performance: identity > motivation, discipline systems, PJ's Brain Type Test • Recovery & tracking: cold plunge/sauna ramping, sleep data that drives changes Website: https://www.xgym.com Book (Kindle): https://www.amazon.com/Cracking-Your-Calorie-Code-Version-ebook/dp/B09HHGBZZN Contact: pj@xgym.com Watch on YouTube: https://www.youtube.com/watch?v=5oPsIwosN1U Subscribe for new episodes weekly and leave a review if this helped your training or coaching.
Send us a textWe are celebrating five years of podcasting in 2025 by going into the archives and remastering the top episodes since June 20, 2020. This is Stephanie, Wright. Thank you for joining us today. Let's get started.Today, we will hear from a man who experienced two miracle healings from colon cancer and prostate cancer. He is the author of the book, "The Miracle Mindset: Cancer is Defeated, I'm Healed." His name is Michael T. Dudley. This is Stephanie Wright, and along with Dr. Apostle Charles G. Wright, we will be listening to Michael Dudley's inspiring interview. If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see the most recent video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist." CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: kids' A1C and tech access correlation, first generic GLP-1 for weight loss approved, Metformin cuts long covid risk, Tandem Diabetes & Eversense updates, and more! Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Accessibility to modern diabetes technology directly correlates with A1c among children with type 1 diabetes globally. Big, cross-sectional study, conducted in 81 pediatric diabetes centers in 56 countries, found that a greater extent of reimbursement for continuous glucose monitoring (CGM), insulin pumps, glucose meters, and insulin was associated with lower A1c levels. Partha S. Kar, MD, Type 1 Diabetes & Technology lead of the National Health Service England, told Medscape Medical News, “As is now being shown in countries such as UK with widespread uptake of technology, there is now population-wide shift in A1c not seen before.” He added, “If policymakers are serious about bringing A1c at a population level to sub-7.5% - 8% levels, then without technology it would be incredibly difficult to achieve, in my experience and opinion. Leaving the median A1c of a population at above 7.5%-8% goes with complications so that's a decision regarding investment many will have to make in the near future.” In an accompanying editorial, Elizabeth R. Seaquist, MD, professor of diabetes, endocrinology, and metabolism and co-director of the Institute for Diabetes, Obesity, and Metabolism at the University of Minnesota, Minneapolis, called it “striking” that access to technology in and of itself was associated with improved glycemic control, given that multidisciplinary team care is also needed to provide education and behavioral or psychological support. https://www.medscape.com/viewarticle/diabetes-tech-access-linked-a1c-kids-t1d-globally-2025a1000nn6 XX A man with type 1 in Illinois has received the first FDA-approved islet-cell replacement treatment, Lantidra, and he is now producing his own insulin. The treatment works by restoring the body's beta cells, potentially eliminating the need for insulin injections. The FDA approved Lantidra (donislecel) in 2023. Lantidra uses donor cells and requires lifelong immunosuppressive drugs. Lantidra is only available at University of Illinois Chicago Health. Other universities, such as the University of Pennsylvania, continue to do islet cell transplants as part of clinical trials. Early data has shown that a majority of participants in the Lantidra clinical study were able to achieve some level of insulin independence, but it's unclear whether the benefits of donislecel outweigh the treatment's safety risks. Nearly 87 percent of participants reported infection-related adverse events, and post-operation complications included liver lacerations, bruising of the liver (hepatic hematoma), and anemia. One patient died of multi-organ failure from sepsis, which Lantidra maker CellTrans stated was “probably related” to the use of either immunosuppression or study drugs. In addition, some industry leaders have raised the question of whether it's ethical to commercialize the use of deceased donor islet cells. https://diatribe.org/diabetes-research/first-fda-approved-islet-cell-transplant-performed?utm_campaign=feed&utm_medium=social&utm_source=later XX Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk's injected Saxenda (liraglutide). The compound, which is a GLP-1 forerunner of Novo's semaglutide products Ozempic and Wegovy, has been approved by the FDA to treat adults with obesity and those who are overweight and have weight-related medical problems. Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds). The treatment is for both triggering and maintaining weight loss. Saxenda is not the first GLP-1 drug that is available as a generic. In June of last year, Teva also was the first company to launch a knockoff version of Novo's Victoza, which is the same compound as Saxenda but has been approved only for patients with Type 2 diabetes. Sales of the branded versions of both Victoza and Saxenda have declined significantly in recent years as demand for Novo's semaglutide and Eli Lilly's tirzepatide products have skyrocketed. In addition, marketers of compounded products have been aggressively competing for market share in the GLP-1 space. https://www.fiercepharma.com/pharma/saxenda-knockoff-teva-launches-first-generic-glp-1-obesity XX Metformin could cut the risk of Long COVID by 64% in overweight or obese adults who started the drug within 90 days of infection. The large observational study, published in Clinical Infectious Diseases, analysed health records of over 624,000 UK adults with COVID-19 between March 2020 and July 2023. Among these, nearly 3,000 patients who began metformin treatment soon after diagnosis were tracked for a year. Compared to non-users, their likelihood of developing Long COVID, defined as persistent symptoms 90 days or more after infection, was dramatically lower. https://www.ndtv.com/health/metformin-cuts-risk-of-long-covid-by-64-why-the-diabetes-pill-is-not-for-everyone-9242332 XX Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don't know they have it, according to data analysis published Monday in the journal The Lancet Diabetes & Endocrinology. The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. “The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford , the lead author of the study. “We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there's a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.” People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said. https://www.cnn.com/2025/09/08/health/diabetes-undiagnosed-half-of-americans-wellness XX A team of Hong Kong scientists is developing an injectable treatment that could potentially improve blood flow in diabetes patients' feet, in the hopes that it will reduce the need for amputation by rebuilding tissue in the arteries. They also hope to apply the treatment to peripheral artery disease or PAD, a condition caused by the build-up of fatty deposits in arteries that affect blood circulation in the feet. “Traditional treatments for people suffering from poor blood flow in their legs are stent implantation or bypass surgery, which is invasive,” said Wong, who is also the co-founder of a biotechnology company called NutrigeneAI. He said it was his dream to turn research in the academic field into actual clinical treatments. But he added that the team still needed three to four years for further research on the treatment. https://www.scmp.com/news/hong-kong/health-environment/article/3324671/hong-kong-scientists-developing-new-blood-flow-treatment-aid-diabetes-patients XX Tandem Diabetes announces Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly upload their pump data to the cloud-based Tandem Source platform.1 The app is expected to be available later this year. The Tandem t:slim mobile app will be available for compatible smartphones in the Apple App Store and Google Play store later in 2025. Once available, Tandem will email eligible customers with instructions on how to download and use the app. https://www.businesswire.com/news/home/20250904665715/en/Tandem-tslim-Mobile-App-Now-Authorized-by-Health-Canada-for-iPhone-and-Android-Phones XX Some changes to how the Eversense CGM will be rolled out.. right now it's being distributed by Ascensia Diabetes Care. Senseonics will take back commercial control of the year long implantable CGM on January 1 in the US and expanding worldwide throughout 2026. The change was a mutual decision, according to the two companies, which said they have signed a memorandum of understanding before a definitive agreement is hammered out by the end of the year. To get started, Senseonics is also set to acquire members of Ascensia's commercial staff—including its CGM president, Brian Hansen, who is slated to become Senseonics' new chief commercial officer. https://www.fiercebiotech.com/medtech/senseonics-retake-eversense-cgm-commercial-control-ascensia-diabetes-care XX Utrecht-based medical device company ViCentra has closed an $85 million Series D round of funding led by Innovation Industries, along with existing investors Partners in Equity and Invest-NL. The round also drew support from EQT Life Sciences and Health Innovations. The recent capital injection will be used to expand ViCentra's manufacturing capabilities, support regulatory approvals, and strengthen commercial rollout across Europe. The funds will also be used to launch the next-generation Kaleido 2 patch pump in Europe and prepare for entry into the U.S. market. The global insulin delivery market is growing quickly due to the increasing number of diabetes cases and demand for effective and user-friendly solutions. The market for insulin pumps is projected to exceed $14 billion by 2034. Patch pumps are the fastest-growing segment, signalling a trend toward compact and wearable devices. And here's where ViCentra is positioned to meet this need, offering a user-friendly, sleek design-led alternative to traditional systems. Kaleido: design-led insulin delivery Kaleido is the smallest and lightest insulin patch pump developed as a lifestyle product with a particular focus on usability and personalisation. Designed to feel more like personal technology than a traditional medical device, Kaleido features premium materials, and users can select their own favourite aluminium shells from a range of ten preset colour options. It integrates with Diabeloop's hybrid closed-loop algorithms (DBLG1 and DBLG2) and is compatible with Dexcom CGM sensors, positioning it within the next generation of automated insulin delivery systems. “Kaleido is a true disruptor — small, discreet, featherlight, and beautifully designed. It empowers people with diabetes by offering a more personal and distinctive choice in both function and style. Built with empathy and precision, it honours those who live with diabetes every day. With this funding, we can now meet surging European demand and fast-track our entry into the U.S. market. This is a pivotal moment — for ViCentra, and for the community we serve,” said Tom Arnold, Chief Executive Officer at ViCentra. Improving the quality of life for diabetic patients ViCentra, led by Tom Arnold, is on a mission to improve the lives of those with diabetes. The company reported that demand for Kaleido in Germany, France, and the Netherlands has already exceeded initial expectations. ViCentra will present updates on Kaleido at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place September 15–19, 2025, in Vienna. The company plans to engage with clinicians, investors, and strategic partners to further its role in the evolving diabetes care landscape. “ViCentra is redefining insulin pump therapy with a platform that truly centres the user experience – combining clinical performance with design simplicity and wearability,” commented Caaj Greebe, Partner at Innovation Industries. “At Innovation Industries, we invest in pioneering companies that blend world-class technology with clear commercial potential. ViCentra exemplifies this by delivering a next-generation system addressing the urgent need for better treatment options in diabetes care. We're proud to lead this investment round and partner with Tom and the team as they deepen and expand their presence in Europe and prepare for U.S. entry.” https://techfundingnews.com/dutch-vicentra-secures-85m-to-bring-insulin-patch-pump-to-more-markets/ XX Luna Diabetes announces they've raised more than 23-million dollars in early venture capital to help continue clinical trials and build out its capacity. This is the company that wants to offer a night time only, tiny, temporary insulin pump – to supplement insulin pen use. According to the company, more than 80% of the improvements in blood sugar from automated insulin delivery systems occur while the user is sleeping. Luna launched a pivotal trial late last year. https://www.fiercebiotech.com/medtech/nighttime-insulin-patch-pump-maker-luna-diabetes-raises-236m XX Following 15 days and 150 fingerpricks, they're here. The results of the “9 sensor samba“. And what a set of a results… Well maybe that's overplaying it a little. Let's just say that the outcome of this n=1 experiment wasn't quite what I expected. One of the established players came out much worse than expected, while a newcomer did a lot better. Let's dig in, and take a look at the variation. https://www.diabettech.com/cgm/the-nine-sensor-samba-results-revealed/ XX Hard work and perseverance define ranch life, but one man in eastern Montana takes it to another level. At 90, he's still living independently on the ranch he built from the ground up. Even more remarkable? He's a type 1 diabetic. Bob Delp still begins each day just like he did decades ago, waking up on his ranch near Richey, Montana. “I always thought if I could ever get a ranch and run a hundred cows, that's what I wanted to do from the time I was a kid,” said Delp. He made that dream real, the hard way; after coming home from the army, he taught school, hayed for seven cents a bale and saved every cent he could. “I worked at it real hard because I always felt like it was going to be part of getting me to that ranch that I always wanted,” said Delp. He did it all while managing type 1 diabetes, a diagnosis that came with few answers and little hope back in the 1950s. “The doctors tell me being a type 1 diabetic for 66 years isn't supposed to happen. Back then, it was a real challenge,” added Delp. Statistically, it's almost unheard of. Fewer than 90 people in the world have lived more than 70 years with type 1 diabetes. Bob credits his late wife, Donna, for helping him beat the odds. “She has been key in that I always ate on time.” They've faced their share of storms, both in health and out on the land. Not long after moving to Richey, a heavy snowstorm nearly tore everything apart just after they'd stepped out for dinner. “If Donna hadn't said it was time to eat, we wouldn't have made it out of there. I guess that's one time that made me happy to have diabetes. And I think that saved us,” said Delp. Now, he still checks his blood sugar daily but trusts his hands more than high-tech insulin pumps. “I'm not satisfied with the sensors they have today. I just don't think they're accurate.” To many, Bob's survival is extraordinary. To him, it's luck. “The genes are there already, I can't change that so I guess I would have to say just lots of good luck,” said Delp. And through it all, optimism has been his compass. “You might fumble the ball, but if you're determined to be a winner, you'll recover that fumble someday,” said Delp. He still welds nearly every day. Not because he has to, but because it keeps him going. “As long as I keep doing something like this, I will not be in the nursing home,” said Delp. https://www.kfyrtv.com/2025/08/09/against-all-odds-montana-man-thrives-with-type-1-diabetes-90/ XX Today, Dexcom is building on this belief and breaking new ground with the launch of its first open call across the U.S. and Canada in search of the next diabetes advocates—giving people with all types of diabetes a once-in-a-lifetime opportunity to raise awareness and share their voice on a global scale in the company's World Diabetes Day campaign (Nov. 14) and beyond. Who is eligible?: Anyone age 2+ living with all types of diabetes or prediabetes can be nominated by themselves or by someone who knows them. Selected candidates will embody strength, advocacy and pride in living with diabetes or prediabetes. Where and how can I nominate myself or someone I know?: Visit Dexcom.com/WorldDiabetesDay When is the deadline to submit a nomination?: Nominations are open from September 10 through September 19 at 12pm PT. What will the selected candidates experience?: An invite to participate in a World Diabetes Day photoshoot in Los Angeles to have their unique story featured in Dexcom's World Diabetes Day campaign The ongoing opportunity to attend events, connect with community, and raise diabetes awareness around the world XX The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more. The 61st annual EASD meeting will take place on September 15-19, 2025, in Vienna, Austria.
Eleven-year-old Toby and his mom share his type 1 diabetes diagnosis, camp adventures, and life with a service dog. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
My guest is Michael Snyder, PhD, professor of genetics at Stanford and an expert in understanding why people respond differently to various foods, supplements, behavioral and prescription interventions. We discuss how to optimize your health and lifespan according to what type of glucose responder you are, which genes you express, your lifestyle and other factors. Dr. Snyder also explains the key ages when you need to be particularly mindful about following certain health practices. We also discuss how people respond in opposite ways to different fiber types. This episode ought to be of interest and use to anyone seeking to understand their unique biological needs and how to go about meeting those needs. Sponsors AGZ by AG1: https://drinkag1.com/huberman Wealthfront*: https://wealthfront.com/huberman David: https://davidprotein.com/huberman Eight Sleep: https://eightsleep.com/huberman Function: https://functionhealth.com/huberman *This experience may not be representative of the experience of other clients of Wealthfront, and there is no guarantee that all clients will have similar experiences. Cash Account is offered by Wealthfront Brokerage LLC, Member FINRA/SIPC. The Annual Percentage Yield (“APY”) on cash deposits as of December 27, 2024, is representative, subject to change, and requires no minimum. Funds in the Cash Account are swept to partner banks where they earn the variable APY. Promo terms and FDIC coverage conditions apply. Same-day withdrawal or instant payment transfers may be limited by destination institutions, daily transaction caps, and by participating entities such as Wells Fargo, the RTP® Network, and FedNow® Service. New Cash Account deposits are subject to a 2-4 day holding period before becoming available for transfer. Timestamps 00:00 Michael Snyder 03:33 Healthy Glucose Range, Continuous Glucose Monitors CGM, Hemoglobin A1c 09:02 Individual Variability & Food Choice, Glucose Spikes & Sleepiness 12:18 Sponsors: AGZ by AG1 & Wealthfront 15:16 Glucose Spikes, Tools: Post-Meal Brisk Walk; Soleus “Push-Ups”; Exercise Snacks 21:06 Glucose Dysregulation, Diabetes & Sub-Phenotypes, Tool: Larger Morning Meal 28:34 Exercise Timing, Muscle Insulin Resistance 30:49 Diabetes Subtyping, Weight, Glucose Control; Incretins 35:41 GLP-1 Agonists, Diabetes, Tool: Muscle Maintenance & Resistance Training 38:40 Metformin, Berberine, Headaches 41:01 GLP-1 Agonists, Cognition, Longevity, Tool: Habits Support Medication; Cycling 47:41 Subcutaneous vs Visceral Fat, Organ Stress 49:10 Sponsors: David & Eight Sleep 51:58 Meal Timing & Sleep, Tools: Post-Dinner Walk, Routines, Bedtime Consistency 57:16 Microbiome, Immune System & Gut; Diet & Individual Variability 1:02:52 Fiber Types, Cholesterol & Glucose, Polyphenols 1:09:50 Food As Medicine; Fiber, Microbiome & Individual Variability; Probiotics 1:18:48 Sponsor: Function 1:20:35 Profiling Healthy Individuals, Genomes, Wearables 1:26:31 Whole-Body MRIs, Nodules, Healthy Baseline, Early Diagnosis 1:34:07 Sensors, CGM, Sleep, Heart Rate Variability HRV, Tools: Mindset Effects, Increase REM 1:39:30 HRV, Sleep, Exercise, Tool: Long Exhales; Next-Day Excitement & Sleep 1:42:48 Organ Aging, “Ageotypes”; Biological Age vs Chronological Age 1:49:41 Longevity, Health Span, Genetics, Blue Zones 1:52:19 Epigenetics, Viral Infection & Disease 1:58:54 ALS, Heritability; Neuroprotection, Nicotine 2:03:47 Air Quality, Allergies, DEET & Pesticides, Inflammation, Mold; Microplastics 2:15:02 Single-Drop Blood Test & Biomarkers, Wearables, Observational Trials 2:20:33 Acupuncture, Blood Pressure 2:26:40 Immersive Events & Mental Health Benefits 2:34:59 Data, Nutrition & Lifestyle; Siloed Health Care vs Personalized Medicine 2:43:06 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, Sponsors, YouTube Feedback, Social Media, Neural Network Newsletter Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Dominic D'Agostino (@DominicDAgosti2) is a tenured associate professor in the Department of Molecular Pharmacology and Physiology at the University of South Florida Morsani College of Medicine and a Visiting Senior Research Scientist at the Institute for Human and Machine Cognition.This episode is brought to you by: Helix Sleep premium mattresses: https://HelixSleep.com/Tim (27% off all mattress orders)Momentous high-quality creatine: https://livemomentous.com/tim (code TIM for up to 35% off)AG1 all-in-one nutritional supplement: https://DrinkAG1.com/Tim (1-year supply of Vitamin D plus 5 free AG1 travel packs)Timestamps:[00:00:00] Start.[00:14:43] Why I'm interested in ketogenic strategies for neurodegenerative prevention.[00:16:18] Mary and Steve Newport's ketone-linked temporary cognitive improvements.[00:18:18] A mechanisms overview for Alzheimer's/dementia.[00:21:25] The immune system as longevity's "fifth horseman" — and why metabolic control is key.[00:22:04] How to measure ketones and GKI.[00:23:00] Fasting vs. ketogenic diet.[00:24:18] There's nothing fishy about sardine fasting.[00:28:32] My hiatal hernia discovery and increased cancer risk concerns.[00:30:04] HSCRP as a superior biomarker to LDL for cardiovascular risk.[00:31:57] Glucose tolerance testing revelations and CGM importance.[00:31:57] Upgrading the metabolic machinery through keto without getting bored.[00:42:07] What do do if you, like Dom and me, are among the 30% who suffer from cholesterol hyperabsorption.[00:43:42] Dom's day-to-day diet regimen.[00:45:56] How Dom optimizes his aging dogs with ketones, SARMs, and supplements.[00:51:30] Supplementing for sleep disruption while fasting.[00:55:41] Why Dom doesn't have misgivings about melatonin.[00:59:15] Shingles prevention through fasting protocols.[01:00:15] Immune system modulation: Innate vs. adaptive, vegan vs. ketogenic.[01:03:54] Dom at 50-something: Current meal timing and composition.[01:05:57] Blue zone observations: Greek and Sardinian longevity habits.[01:08:16] Ketogenic diet initiation tips: MCT, electrolytes, and fasted cardio.[01:15:18] Ketone metabolic therapy for cancer.[01:18:15] The metabolic psychiatry revolution.[01:22:10] The soothing effects of hyperbaric oxygen and ketosis on seizure sufferers.[01:28:27] Metformin vs. berberine.[01:31:43] The low-dose neuroprotective potential of GLP-1 drugs.[01:34:58] NAD research: MIB-626 and stabilized forms for mitochondrial health.[01:39:48] Idebenone, CoQ10, and the Deanna protocol for ALS.[01:42:05] Dom's supplement short list: CoQ10, creatine, ketones, vitamin D, melatonin.[01:44:43] KetoNutrition.org, Metabolic Health Summit, Audacious Nutrition, veteran-focused research protocols, and other parting thoughts.*Show notes for this episode: https://tim.blog/2025/09/03/dr-dominic-dagostino-all-things-ketones/For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Send us a textMost people don't realize it, but one of the simplest ways to understand your overall health is by tracking your blood sugar. In this eye-opening conversation, Dr. Boz, Annette Bosworth, MD and I dive into why blood glucose monitoring—and especially using a Continuous Glucose Monitor (CGM)—can give you a clear picture of how your body is functioning.From energy crashes to long-term chronic disease, blood sugar plays a bigger role in your health than you may think. And the best part? You don't need to be a scientist to make sense of it.We break it down in a way anyone can understand—engaging, thought-provoking, and sprinkled with a bit of humor—so you'll walk away with practical insights you can actually use. What You'll Learn in This Episode:Why insulin resistance is at the root of so many modern health struggles.How tracking your blood sugar (even with a simple monitor) can transform your health decisions.The surprising link between everyday choices and your long-term risk for chronic disease.Why CGMs aren't just for diabetics—they're a powerful tool for anyone serious about health.Simple, actionable tips to start taking control of your blood sugar today. Time Stamps01:01 – Welcome to the 'Strong by Design' podcast! 02:21 – Meet today's special guest, Dr. Boz (Annette Bosworth, MD) 03:30 – What happened during the first days in Florida 07:33 – Finding better health in the 21st century 12:16 – Why knowing more about our bodies hasn't made us healthier 13:50 – Learn more about blood sugar and why it matters 18:15 – Know the real threshold for diabetes 21:15 – Why the insulin resistance problem is so hard 27:39 – The hidden reason behind “it's not working” 31:21 – Discover the role of muscle mass 34:54 – The healthy range for ketones revealed 38:45 – What Chris learned from fasting in the past 45:12 – Revisiting Dr. Boz's very first appearance 46:22 – Everything you need to know about CGM 51:34 – What healthy eating really looks like 56:55 – Foods that secretly spike your sugar 59:58 – Inside the 21-Day Metabolic Kick 1:06:43 – Why you might be having health issues 1:09:37 – Stay connected beyond the episode with Dr. Boz 1:14:00 – Please share and leave ratings & reviews for the SBD podcast! Resources:Dr Boz YouTube Channel Connect with Dr Boz:Instagram Connect with Chris:InstagramGrab your ACV Gummies, Buy One Get One FREE at CriticalBench.com, look for 'ACV Sale' in top right of page.Support the showConnect w/ CriticalBench: Youtube Facebook Instagram CriticalBench.com StrongByDesignPodcast.com
Sarah, an anesthesiologist and mom of four, shares her family's adventures traveling the world while managing her 9-year-old son's type 1 diabetes. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi twiist AID System Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
Did you know that brain fog can be a metabolic warning sign? In this episode, Dr. Austin Perlmutter breaks down how blood sugar swings, inflammation, and poor metabolic health silently chip away at your brain function over time. We also talk about how to eat to protect your mood, cognition, and long-term brain health, including the latest research on how to prevent dementia and Alzheimer's disease.Timestamps:[1:38] Intro[3:43] Conversation with Dr. Austin Perlmutter[10:27] You mentioned that inflammation can manifest in different ways, is there a reason it manifests a different way for one person than another?[17:53] What is excites you the most as far as the shifts we can make that result in better cognitive function?[29:34] Do you agree with Alzheimer's being called “type 3 diabetes”?[38:07] Are you recommending that people wear a CGM or that they get their metabolic markers tested regularly, and if so, what are those markers we should be looking at?[50:13] How can we improve brain fog after 40?[59:23] Do you think our screens and social media habits are changing our brain function, and is there anything we can be doing nutritionally especially if we have to be on our computers all day for work?Episode Links:Dr. Austin Perlmutter's Website Follow Dr. Austin on InstagramBrain Wash: Detox Your Mind for Clearer Thinking, Deeper Relationships, and Lasting Happiness Big Bold HealthDr. Austin's YouTubeTop Causes of Brain FogBiomarkers:Hemoglobin A1cBasic metabolic panel (fasting insulin, fasting glucose)Lipid panel - Triglycerides are the key markerWaist to hip ratioSMASH fishSponsors:Go to https://thisisneeded.com/ and use coupon code WELLFED for 20% off your first order.Go to boncharge.com/WELLFED and use coupon code WELLFED to save 15% off any order.Go to http://mdlogichealth.com/whey-protein, and use coupon code WELLFED for 10% off.Go to wellminerals.us/creatine and use code WELLFED to get 10% off your order.